Latest Competition News

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Big River Industries reported a modest revenue decline in FY25 amid tough market conditions but demonstrated operational improvements and efficiency gains, setting the stage for a cautiously optimistic FY26.

Pinnacle Investment Management has secured a strategic foothold in Japan’s private markets by acquiring up to 13% of Advantage Partners, complementing its strong FY25 growth and global expansion ambitions.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Comms Group Limited reported a steady 2% revenue increase in FY25, hitting the highest gross margin in five years, while targeting over $75 million in run-rate revenue post-TasmaNet integration.

Earth’s Energy Limited has halted further exploration spending on its South Australian and Queensland geothermal assets following an independent review, shifting focus to new project opportunities. The company maintains a healthy cash position while managing its existing licences conservatively.

Weebit Nano has reported a fourfold revenue increase in FY25, driven by a landmark licensing agreement with semiconductor giant onsemi and key automotive-grade qualification for its ReRAM technology.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.

Region Group delivered solid financial results for FY25 with modest growth in funds from operations and assets under management, while announcing a planned CEO retirement and maintaining positive guidance for FY26.

EMVision Medical Devices has closed its $2 million Share Purchase Plan ahead of schedule due to strong investor demand, signaling robust market interest in its neurodiagnostic technology.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy shares at a discount, following a recent A$130 million institutional placement and its acquisition of IMPECT GmbH.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 in shares at a discount, following a successful A$130 million institutional placement. The capital raise supports the recent acquisition of IMPECT GmbH and future strategic opportunities.